REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 160 filers reported holding REVANCE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 2.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,604,929 | +12.9% | 314,292 | +149.1% | 0.01% | -18.2% |
Q2 2023 | $3,193,818 | -65.4% | 126,188 | -56.0% | 0.01% | -92.0% |
Q1 2023 | $9,230,162 | -1.7% | 286,562 | -43.7% | 0.14% | -19.3% |
Q4 2022 | $9,390,510 | -33.5% | 508,695 | -2.7% | 0.17% | -36.7% |
Q3 2022 | $14,122,000 | +119.8% | 523,045 | +12.5% | 0.27% | +52.5% |
Q2 2022 | $6,426,000 | -34.8% | 464,970 | -8.1% | 0.18% | -33.0% |
Q1 2022 | $9,861,000 | +69.1% | 505,701 | +41.6% | 0.26% | +45.9% |
Q4 2021 | $5,830,000 | +284.1% | 357,237 | +555.8% | 0.18% | +320.9% |
Q3 2021 | $1,518,000 | -52.1% | 54,477 | -49.0% | 0.04% | -60.2% |
Q2 2021 | $3,167,000 | +61.3% | 106,859 | +52.1% | 0.11% | -5.3% |
Q1 2021 | $1,963,000 | -2.9% | 70,249 | -1.6% | 0.11% | -15.6% |
Q4 2020 | $2,022,000 | +354.4% | 71,365 | +108.1% | 0.14% | +175.5% |
Q2 2019 | $445,000 | +1.6% | 34,300 | +94.4% | 0.05% | -76.0% |
Q3 2018 | $438,000 | – | 17,644 | – | 0.20% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Essex Woodlands Management, Inc. | 3,342,047 | $94,714,000 | 24.58% |
Palo Alto Investors LP | 2,673,313 | $75,762,000 | 3.97% |
Evolutionary Tree Capital Management, LLC | 89,348 | $2,532,000 | 1.93% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,121,152 | $31,773,000 | 1.12% |
ArrowMark Colorado Holdings LLC | 2,964,135 | $84,004,000 | 0.65% |
Rhenman & Partners Asset Management AB | 220,000 | $6,235,000 | 0.51% |
Fosun International Ltd | 233,841 | $6,627,000 | 0.43% |
OSTERWEIS CAPITAL MANAGEMENT INC | 174,970 | $4,959,000 | 0.30% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 76,671 | $2,173,000 | 0.27% |
Tekla Capital Management LLC | 213,808 | $6,059,000 | 0.21% |